The outbreak of COVID-19 in Beijing has been sporadic since the beginning of 2022 and has become increasingly severe since October. In China’s policy of insisting on dynamic clearance, fine-grained management has become the focus of current epidemic prevention and control. In this paper, we conduct a refined COVID-19 risk prediction and identification of its influencing factors in Beijing based on neighborhood-scale spatial statistical units. We obtained geographic coordinate data of COVID-19 cases in Beijing and quantified them into risk indices of each statistical unit. Additionally, spatial autocorrelation was used to analyze the epidemic risk clustering characteristics. With the multi-source data, 20 influencing elements were constructed, and their spatial heterogeneity was explored by screening 8 for Multiscale Geographically weighted regression (MGWR) model analysis. Finally, a neural network classification model was used to predict the risk of COVID-19 within the sixth ring of Beijing. The MGWR model and the neural network classification model showed good performance: the R2 of the MGWR model was 0.770, and the accuracy of the neural network classification model was 0.852. The results of this study show that: (1) COVID-19 risk is uneven, with the highest clustering within the Fifth Ring Road of Beijing; (2) The results of the MGWR model show that population structure, population density, road density, residential area density, and living service facility density have significant spatial heterogeneity on COVID-19 risk; and (3) The prediction results show a high COVID-19 risk, with the most severe risk being in the eastern, southeastern and southern regions. It should be noted that the prediction results are highly consistent with the current epidemic situation in Shijingshan District, Beijing, and can provide a strong reference for fine-grained epidemic prevention and control in Beijing.
The Omicron variant of COVID-19, which emerged at the end of 2021, has caused a new wave of infections around the world and is causing a new wave of the crisis due to the extreme variability of the pathogen. In response to public health emergencies such as SARS and COVID-19, the first task is to identify the vulnerabilities of regional health systems and perform a comprehensive assessment of the region’s resilience. In this paper, we take the carrying capacity of medical resources as the focus; evaluate the medical, human, and financial resources of various regions; and construct an epidemic safety index based on the actual situation or future trend of the epidemic outbreak to evaluate and predict the risk level of each region in response to the epidemic. The study firstly evaluates the epidemic safety index for each province and city in China and 150 countries around the world, using the first wave of the COVID-19 epidemic in 2020 and the Omicron variant virus in 2022 as the background, respectively, and justifies the index through the actual performance in terms of epidemic prevention and control, based on which the epidemic safety index for 150 countries in the next year is predicted. The conclusions show that Europe, the Americas, and parts of Asia will face a significant risk of epidemic shocks in the coming period and that countries need to formulate policies in response to the actual situation of the epidemic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.